Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 4, 2017, Pages

  Clarkesmith, Danielle E ^a   Pattison, Helen M ^b   Khaing, Phyo H ^a   Lane, Deirdre A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ANXIETY; ATRIAL FIBRILLATION; ATTITUDE TO HEALTH; ATTITUDE TO ILLNESS; BEHAVIOR THERAPY; DEPRESSION; HEALTH BELIEF; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MEDICATION COMPLIANCE; META ANALYSIS; PATIENT EDUCATION; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL-BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF CARE; SELF MONITORING; SYSTEMATIC REVIEW; TREATMENT DURATION; AGED; BLOOD; CHRONIC DISEASE; COMPLICATION; DECISION SUPPORT SYSTEM; DRUG MONITORING; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PREVENTION AND CONTROL; PROCEDURES; STANDARDS; STROKE;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ANXIETY; ATRIAL FIBRILLATION; CHRONIC DISEASE; DECISION SUPPORT TECHNIQUES; DRUG MONITORING; HUMANS; INTERNATIONAL NORMALIZED RATIO; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF CARE; STROKE;

EID: 85017178316     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008600.pub3     Document Type: Review

References (187)

1. Beyth RJ, Landefeld CS. Multicomponent comprehensive care was as effective as usual care for decreasing major bleeding in older patients on warfarin. Evidence Based Medicine 2001;6:116. 2908622
2. Beyth RJ, Quinn L, Landefeld S. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. Annals of Internal Medicine 2000;133(9):687-95. 2908623
3. Christensen TD, Maegaard M, Sorensen HT, Hjortdal VE, Hasenkam . Self-versus conventional management of oral anticoagulant therapy. American Journal of Cardiovascular Drugs 2007;7(3):191-7. 2908626
4. Christensen TD, Maegaard M, Sorensen HT, Hjortdal VE, Hasenkam JM. Self-management versus conventional management of oral anticoagulant therapy: A randomised, controlled trial. European Journal of Internal Medicine 2006;17:260-6. 2908625
5. Clarkesmith DE, Pattison HM, Lip GYH, Lane DA. Educational intervention improves anticoagulation control in atrial fibrillation patient. PLoS One 2013;8(9):e74037. 5372374
6. Smith DE, Borg Xuereb C, Pattison HM, Lip GYH, Lane DA. TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control and outcome of Treatment with warfarin (TREAT). BMC Cardiovascular Disorders 2010;10:21. 2908788
7. Gadisseur APA, Breukink-Enghers WGM, van der Meer FJM, van den Besselaar AMH, Sturk A, Rosendaal FR. Comparison of the quality of oral anticoagulant therapy through patient self-management by specialized anticoagulation clinics in the Netherlands. Archives of Internal Medicine 2003;163(24):2639-46. 2908628
8. Gadisseur APA, Kaptein AA, Breukink-Engbers WGM, Van der meer FJM, Rosendaal FR. Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of care. Journal of Thrombosis and Haemostasis 2004;2:584-91. 2908629
9. Hendriks J, Crijins H, De Wit R, Vrijhoef H, Tieleman R. A disease management program in atrial fibrillation: a guidelines-based, nurse-driven, ICT-supported outpatient clinic. Acta Cardiologica 2009;64(1):144-5. 5372376
10. Hendriks J, Tomini F, van Asselt T, Crijins H, Vrijhoef H. Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation. Europace 2013;15:1128-35. 5372377
11. Hendriks JML, Crijins HJGM, Vrijhoef HJM. Integrated chronic care management for patients with atrial fibrillation: a rationale for redesigning atrial fibrillation care. Journal of Atrial Fibrillation 2015;7(5):45-50. 5372378
12. Hendriks JML, Vrijhoef HJM, Crijins HJGM, Brunner-La Rocca HP. The effect of a nurse-led integrated chronic care approach on quality of life in patients with atrial fibrillation. Europace 2014;16:491-9. 5372379
13. Hendriks JML, de Wit R, Crijins HJGM, Vrijhoef HJM, Prins MH, Pisters R, et al. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronis care vs. routine clinical care in ambulatory patients with atrial fibrillation. European Heart Journal 2012;33:2692-9. 5372380
14. Hendriks JML, de Wit R, Vrijhoef HJM, Tieleman RF, Crijins HJGM. An integrated chronic care program for patients with atrial fibrillation: Study protocol and methodology for an ongoing prospective randomised controlled trial. International Journal of Nursing Studies 2010;47:1310-16. 5372381
15. Man-Son-Hing M, Laupacis A, O'Connor AM. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: A randomized controlled trial. JAMA 1999;282(8):737-43. [DOI: 10.1001/jama.282.8.737]2908631
16. McAlister FA, Man-Son-Hing M, Straus SE, Ghali WA, Anderson D, Majumdar SR, et al. Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomised trial. Canadian Medical Association Journal 2005;173(5):496-501. 2908633
17. McAlister FA, Man-Son-Hing M, Straus SE, Ghali WA, Gibson P, Anderson D, et al. A randomised trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTNI4429643]. BMC Cardiovascular Disorders 2004;4:5. 2908634
18. Polek C, Hardie T. Warfarin use post hospitalization: pilot comparative effectiveness of telephone follow-up. Rehabilitation Nursing 2012;37(2):80-7. 2908636
19. Thomson RG, Eccles MP, Steen IN, Greenaway J, Stobbart L, Murtagh MJ, et al. A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: a randomised controlled trial. Quality and Safety in Health Care 2007;16:216-23. [DOI: 10.1136/qshc.2006.018481]2908638
20. Voller H, Glatz J, Taborski U, Bernado A, Dovifat C, Bunkard G, et al. Background and test plan of the study for self-management of anticoagulation in patients with non-ventricular atrial fibrillation [Hintergrund und Prufplan der studie zum Selbstmanagement der Antikoagulation bei Patient mit nichtvalvularem Vorhofflimern (SMAAF-studie)]. Zeitschrift fur Kardiologie 2000;89:284-8. 2908640
21. Voller H, Glatz J, Taborski U, Bernardo A, Dovifat C, Heidinger K. Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study) [Selbstmanagement de antikoagulation bei patienten mit nichtvalvularem vorhofflimmern]. Zeitschrift fur Kardiologie 2005;94(3):183-6. 2908641
22. Hua TD, Vormfelde SV, Abed MA, Schneider-Rudt H, Sobotta P, Friede T, et al. Practice nurse-based, individual and video assisted patient education in oral anticoagulation - Protocol of a cluster-randomized controlled trial. BMC Family Practice 2011;12:17. 2908786
23. Vormfelde SV, Abu Abed M, Hua TD, Schneider S, Friede T, Chenot JF. Educating orally anticoagulated patients in drug safety- a cluster randomized study in general practice. Dtsch Arztebl Int 2014;111:607-14. 5372382
24. Al-Meshal N, Al-Sultan R, Al Moones S, Al-Sudaus H, Bawazeer G, Zayed E, et al. The impact of a structured educational program on patient knowledge about their warfarin therapy. International Journal of Pharmacy Practice 2013;21:28. 5372384
25. Armstrong EP, Chemodurow L, Christensen S, Johnson ES. A pre- post-evaluation of implementing an inpatient monitoring and education program. Pharmacy Practice 2011;9(2):101-5. 2908643
26. Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A pharmacist-led mutlidisciplinary intervention. Journal of the American Geriatrics Society 2005;53:1912-20. [DOI: 10.1111/j.1532-5415.2005.53564.x]2908645
27. Baker D, Roberts DE, Newcombe RG, Fox KAA. Evaluation of drug information for cardiology patients. British Journal of Clinical Pharmacy 1991;31:525-31. 2908647
28. Barcellona D, Contu P, Marongiu F. A two-step educational approach for patients taking oral anticoagulants does not improve therapy control. Journal of Thrombosis and Thrombolysis 2006;22:185-90. [DOI: 10.1007/s11239-006-9027-2]2908649
29. Batty G, Oborne CA, Hooper R, Jackson S. Investigation of intervention strategies to increase the appropriate use of antithrombotics in elderly hospital inpatients with atrial fibrillation. The Journal of Clinical Governance 2001;9:115-22. 2908651
30. Bereznicki L, Jackson S, Peterson G. Supervised patient self-testing of warfarin therapy using an online system. Journal of Medical Internet Research 2013;15:e138. 5372386
31. Blaise S, Satger B, Fontaine M, Yver J, Rastel D, Toffin L, et al. Evaluation of an education program for patients taking oral anticoagulants: Experience of the GRANTED network in Isere [Evaluation d'un programme d'education therapeutique pour les traitments anticoagulants oraux: exerience du reseau Ville-Hopital GRANTED du secteur Sud-Isere]. Journal des Maladies Vasculaires 2009;34:346-53. [DOI: 10.1016/j.jmv.2009.07.088]2908653
32. Bloomfield HE, Krause A, Greer N, Taylor BC, MacDonald R, Rutks I, et al. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Annals of Internal Medicine 2011;154(7):472-w-160. 2908655
33. Bump CM, Campbell JG. The relationship of patient education to the clinical course of patients receiving anticoagulants. Abstracts of Hospital Management Studies 1977;14(2):18091. 2908657
34. Burns S. Application of the theory of planned behavior to oral anticoagulation therapy. Nursing and Health Sciences 2009;11:98-101. [DOI: 10.1111/j.1442-2018.2009.00426.x]2908659
35. Castelino RL, Chen TF, Guddattu V, Bajorek BV. Use of evidence-based therapy for the prevention of cardiovascular events among older people. Evaluation & the Health Professions 2010;33(3):276-301. 2908661
36. Chan FWH, Wong RSM, Lau WH, Chan TYK, Cheng G, You JHS. Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial. British Journal of Clinical Pharmacology 2006;62(5):601-9. [DOI: 10.1111/j.1365-2125.2006.02693.x]2908663
37. Christensen H, Lautertein JJ, Sorensen PD, Petersen ERB, Madsen JS, Brandslund I. Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health 2011;17(3):169-76. [DOI: 10.1089/tmj.2010.0128]2908665
38. Claes N, Buntinx F, Vijgen J, Arnout J, Vermylen J, Fieuws S, et al. The Belgian improvement study on oral anticoagulation therapy: a randomized clinical trial. European Heart Journal 2005;26(20):2159-65. 2908667
39. Claes N, Moeremans K, Frank B, Jef A, Jos V, Herman VL, et al. Estimating the cost-effectiveness of quality-improving interventions in oral anticoagulation management within general practice. Value in Health 2006;9(6):369-76. [DOI: 10.1111/j.1524-4733.2006.00129]2908669
40. Corbella A, Bottari L, Cevasco I, Giacobbe S, Roba I, Rossini S, et al. Patients in chronic anticoagulation therapy: the organization of an educational program run by nurses and the assessment of patients' satisfaction [Le persone in Terapia Anticoagulante Orale (TAO): costruzione di un intervento gestito dagli infermieri e valutazione del gradimento]. Assistenza Infermieristica e Ricerca 2009;28(2):65-72. 2908671
41. Cordasco KM, Asch SM, Bell DS, Guterman JJ, Gross-Schulman S, Ramer L, et al. A low-literacy medication education tool for safety-net hospital patients. American Journal of Preventative Medicine 2009;37(6 Suppl 1):S209-16. [DOI: 10.1016/j.amepre.2009.08.018]2908673
42. Cromheecke ME, Levi M, Colly LP, de Mol BJM, Prins MH, Hutten BA, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000;356(8):97-102. 2908675
43. Cromheecke ME, Levi M, Colly LP. Self management of long term oral anticoagulation was as effective as specialist anticoagulation clinic management. Evidence-Based Medicine 2001;6(2):41. 2908677
44. Davis NJ, Billett HH, Cohen HW, Arnsten JH. Impact of adherence, knowledge, and quality of life on anticoagulation control. Annals of Pharmacotherapy 2005;39(4):632-6. 2908679
45. Dolor RJ, Ruybalid RL, Uyeda L, Edson RG, Phibbs C, Vertrees JE, et al. An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA cooperative study #481 - The home INR study (THINRS). Journal of Thrombosis and Thrombolysis 2010;30:263-75. 2908681
46. Duran-Parrondo C, Vazquez-Lago JM, Campos-Lopez AM, Figueras A. Impact of a pharmacotherapeutic programme on control and safety of long-term anticoagulation treatment. Drug Safety 2011;34(6):489-500. 2908683
47. Field TS, Tjia J, Mazor KM, Donovan JL, Kanaan AO, Harrold LR, et al. Randomized trial of a warfarin communication protocol for nursing homes: an SBAR-based approach. The American Journal of Medicine 2011;124:2. 2908685
48. Fitzmaurice DA, Hobbs FDR, Murray ET, Bradley CP, Holder R. Evaluation of computerized decision support for oral anticoagulation management based in primary care. British Journal of General Practice 1996;46:533-5. 2908687
49. Fitzmaurice DA, Hobbs FD, Murray ET. A nurse led clinic and computer decision support software for anticoagulation decisions were as effective as a hospital clinic. Evidence Based Medicine 2001;6:61. 2908690
50. Fitzmaurice DA, Hobbs FD, Murray ET, Holder RL, Allan TF, Rose PE. Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomised, controlled trial. Archives of Internal Medicine 2000;160(15):2343-8. 2908689
51. Fitzmaurice DA, Murray ET, Gee KM. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology 2002;55:845-9. [DOI: 10.1136/jcp.55.11.845]2908692
52. Fitzmaurice DA, Murray ET, McCahon MD, Holder R, Raferty JP, Hussain S, et al. Self management of oral anticoagulation: randomised trial. BMJ 2005;331(7524):1057. Erratum in: BMJ 2005 331(7528):1330. [DOI: 10.1136/bmj.38618.580903.AE; ISRCTN 19313375]2908693
53. Murray E, Fitzmaurice D, MaCahon D, Fuller C, Sandhur H. Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ 2004;328(21):437. 2908694
54. Fraenkel L, Street RL, Fried TR. Development of a tool to improve the quality of decision making in atrial fibrillation. BMC Medical Informatics and Decision Making 2011;11:59. 2908696
55. Gardiner C, Williams K, Longair I, Mackie IJ, Machin SJ, Cohen H. A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. British Journal of Haematology 2006;132:598-603. [DOI: 10.1111/j.1365-2141.2005.05899]2908698
56. Gouin-Thibault I, Levy C, Pautas E, Cambus JP, Drouet L, Mahe I, et al. Improving anticoagulation control in hospitalized elderly patients on warfarin. Journal of the American Geriatrics Society 2010;58:242-7. 2908700
57. Grunau B, Wiens MO, Harder KK. Patient self-management of warfarin therapy. Canadian Family Physician 2011;57:292-8. 2908702
58. Hasan SS, Sharmala R, Syed IA, Basariah N, Chong DWK, Mei TK, et al. Factors affecting warfarin-related knowledge and INR control of patients attending physician- and pharmacist-managed anticoagulation clinics. Journal of Pharmacy Practice 2011;24(5):485-93. 2908704
59. Heidbuchel H, Berti D, Campos M, Destenghe L, Freixo A, Nunes A, et al. Implementation of non-vitamin K antagonist oral anticoagulants in daily practice: the need for comprehensive education for professionals and patients. Thrombosis Journal 2015;13:1-14. 5372388
60. Holbrook A, Labiris R, Goldsmith CH, Ota K, Harb S, Sebaldt RJ. Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial. Canadian Medical Association Journal 2007;176(11):1583-7. 2908706
61. Jackson SL, Peterson M, Vial JH. A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation. The Annals of Pharmacotherapy 2004;38:1794-9. [DOI: 10.1345/aph.1E152]2908708
62. Jank S, Kappler M, Markmann A, Bertsche T, Klimm HD, Haefeli WE. Impact of an individualised computer-assisted educational intervention on management of anticoagulation therapy. Basic and Clinical Pharmacology and Toxicology 2009;106(6):526. 5372390
63. Khan TI, Kamali F, Kesteven P, Avery P, Wynne H. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology 2004;126:557-64. 2908710
64. Krause A, Bloomfield H, Wilt T. Safety and effectiveness of patient-managed outpatient anticoagulation: A systematic review. Journal of General Internal Medicine 2010;25:S387. 2908712
65. Lakshmi R, James E, Kirthivasan R. Study on the impact of clinical pharmacist's interventions in the optimal use of oral anticoagulants in stroke patients. Indian Journal of Pharmaceutical Sciences 2013;75:53-59. 5372392
66. Landefeld CS, Anderson PA. Guideline-based consultation to prevent anticoagulation-related bleeding. Annals of Internal Medicine 1992;116(10):829-37. 2908714
67. Leger S, Allenet B, Pichot O, Figari G, Calop J, Carpentier P, et al. Impact of an education program on patient behaviour favoring prevention of drug-related adverse events: a pilot study in patients receiving oral anticoagulants for thromboembolic venous disease [Impact d'un pragramme d'education therapeutique sur les attitudes de prevention vis-s-vis du risque iatrogene: etude pilote controlee visant les patients sous-anticoagulants oraux pour maladie thromboembolique veineuse]. Journal des Maladies Vasculaires 2004;29(3):152-8. 2908716
68. Machtinger EL, Wang F, Chen LL, Rodriguez M, Wu S, Schilinger D. A visual medication schedule to improve anticoagulation control: A randomised controlled trial. The Joint Commission Journal on Quality and Patient Safety 2007;33(10):625-35. 2908718
69. Matchar DB, Jacobson AK, Edson RG, Lavori PW, Ansell JE, Ezekowitz MD, et al. The impact of patient self-testing of prothrombin time for managing anticoagulation: Rationale and design of VA cooperative study #481 - the home INR study (THINRS). Journal of Thrombosis and Thrombolysis 2005;19(3):163-72. 2908720
70. Matchar DB, Jacobson A, Dolor R, Edson R, Uyeda L, Phibbs CS, et al. Effect of home testing of international normalised ratio on clinical events. The New England Journal of Medicine 2010;363(17):1608-20. 2908722
71. Mazor KM, Baril J, Dugan E, Spencer F, Burgwinkle P, Gurwitz JH. Patient education about anticoagulant medication: Is narrative evidence or statistical evidence more effective?. Patient Education and Counseling 2007;69:145-57. [DOI: 10.1016/j.pec.2007.08.010]2908724
72. McCahon D, Fitzmaurice DA, Murray ET, Fuller CJ, Hobbs RFD, Allan TF, Raferty JP. SMART: Self-management of anticoagulation, a randomised trial. BMC Family Practice 2003;4:11. 2908726
73. McCahon D, Murray ET, Murray K, Holder RL, Fitzmaurice DA. Does self-management of oral anticoagulation therapy improve quality of life and anxiety?. Family Practice 2011;28(2):134-40. 2908727
74. Megden TH, Heidgen FJ, Vetter H. Optimization of long term control of oral anticoagulation by patient self-management [Verbesserung der langzeitkontrolle der oralen antikoagulation durch patienten-selbstmanagement]. Herz Kreislauf 1999;31(10):393-7. 2908729
75. Menendez-Jandula B, Souto J, Oliver A, Monserrat I, Quintana M, Gich I, et al. Comparing self-management of oral anticoagulant therapy with clinic management. Annals of Internal Medicine 2005;145:1-10. 2908731
76. Menendez-Jandula B, Souto JC, Oliver A. Patient self management of anticoagulants resulted in fewer major complications than clinic-based management. Evidence Based Nursing 2005;142:1-10. 2908732
77. Moore SJ, Blair EA, Steeb D, Reed BN, Hull JH, Crisp B, et al. Use of video technology to improve pharmacist efficiency and patient comprehension of anticoagulation education. Pharmacotherapy 2013;33(10):e264. 5372394
78. Moore SJ, Blair EA, Steeb DR, Reed BN, Hull JH, Rodgers JE. Impact of video technology on efficiency of pharmacist-provided anticoagulation counseling and patient comprehension. Annals of Pharmacotherapy 2015;49:631-8. 5372395
79. Morin MM, Weimer CA. Design and implementation of an ambulatory anticoagulation therapy program using RN: Pharmacy model. Journal of Thrombosis and Thrombolysis 2015;39(3):413. 5372397
80. Moss RC, Lowe GC, Frampton CA, Revell P. A nurse-led randomised controlled trial of a structured educational programme for patients starting warfarin therapy. Journal of Research in Nursing 2014;19:402-12. 5372399
81. Nedaz M. Atrial fibrillation, anticoagulation and shared decision making [Fibrillation auriculaire et partage avec le patient de la decision d'anticoaguler]. Medecine et Hygiene 2002;60(2412):2054-8. 2908734
82. Nilsson N, Eide TH, Kjeldhy C, Refsum N, Dahle G. What knowledge do patients on warfarin have about their treatment, and may patient education by a pharmacist improve their knowledge?. International Journal of Clinical Pharmacy 2011;33:418. 2908736
83. O'Sullivan D, Mahony D, O'Connor MN, Gallagher P, Gallagher J, Cullinan S, et al. Prevention of adverse drug reactions in hospitalised older patients using a software-supported structured pharmacist intervention: a cluster randomised controlled trial. Drugs and Ageing 2016;33:63-73. 5372401
84. Peng B, Ni J, Anderson CS, Zhu Y, Wang Y, Pu C, et al. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China. Stroke 2014;45:515-9. 5372403
85. Pernod G, Labarere J, Yver J, Satger B, Allenet B, Berremili T, et al. EDUC'AVK: Reduction of oral anticoagulant-related adverse events after patient education: A prospective multicenter open randomized study. Journal of General Internal Medicine 2008;23(9):1441-6. [DOI: 10.1007/s11606-008-0690-1]2908738
86. Polzien G. Prevent medication errors: a new year's resolution. Home Healthcare Nurse 2007;25(1):59-62. 2908740
87. Lees KR, Sim I, Wier CJ, Erwin L, McAlpine C, Rodger J, et al. Cluster-randomized, controlled trial of computer-based decision support for selecting long-term anti-thrombotic therapy after acute ischaemic stroke. QJM: An International Journal of Medicine 2003;96:143-53. [DOI: 10.1093/qjmed/hcg019]2908742
88. Qvist I, Hendriks JML, Moeller DS, Albertsen AE, Mogensen HM, Oddershede GD, et al. Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population. Open Heart 2016;3:e000335. 5372405
89. Reverdin S, Schnetzler B, Gagneux G, Gavignet C, Boehlen F, Moerloose P. Implementation of an INR self-testing and self-management programme in common ambulatory private practice: our experience with 90 patients. Swiss Medical Weekly 2011;141:w13199. 2908744
90. Ryan F, Byrne S, OShea S. Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis 2009;7:1284-90. 2908746
91. Saokaew S, Permsuwan U, Chaiyakunapruk N, Nathisuwan S, Sukonthasarn A. Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis 2010;8:2418-27. 2908748
92. Satger B, Blaise S, Fontaine M, Yver J, Allenet B, Baudrant M, et al. Therapy education for patients receiving oral anti-coagulants vitamin K antagonists [Education therapeutique des patients traites par anticoagulants oraux antivitamines k]. La Presse Medicale 2009;38(12):1780-7. [DOI: 10.1016/j.lmp.2009.07.019]2908750
93. Sawicki PT, for the working group for the study of patient self-management of oral anticoagulation. A structured teaching and self-management program for patients receiving oral anticoagulation. JAMA 1999;281(2):145-50. 2908752
94. Sawicki PT, Blaser B, Didjurgeit U, Kaiser T, Kleepies C, Schmitz N, et al. Long-term results of patient's self-management of oral anticoagulation. Journal of Clinical and Basic Cardiology 2003;6(1-4):59-62. 2908754
95. Siebenhofer, A, Rakovac I, Kleepies C, Piso B, Didjurgeit U. Self-management of oral anticoagulation in the elderly: Rationale, design, baselines and oral anticoagulation control after one year follow-up. Blood Coagulation, Fibrinolysis and Cellular Haemostasis 2007;97:408-16. [DOI: 10.1160/TH06-08-0482]2908756
96. Stafford L, Peterson GM, Bereznicki LRE, Jackson S. A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'role of community pharmacy in post hospital management of patients initiated on warfarin' study. BMC Health Services Research 2011;11:16. 2908790
97. Stone S, Holden A, Knapic N, Ansell J. Comparison between videotape and personalized patient education for anticoagulant therapy. The Journal of Family Practice 1989;29(1):55-7. 2908758
98. Sunderji R, Gin K, Shalansky K, Carter C, Chambers K, Davies C, et al. Clinic impact of point-of-care vs laboratory measurement of anticoagulation. American Journal of Clinical Pathology 2005;123:184-8. 2908760
99. Suriano M, Tavelli A, Anania S, Braham S, Moia M, Moja EA. Improvement of the time in the therapeutic range (TTR) after a psycho-educational course in patients on oral anticoagulant therapy (OAT). Thrombosis Research 2014;134:S12. 5372407
100. Taylor FC, Gray A, Cohen H, Gaminara L, Ramsay M. Costs and effectiveness of a nurse specialist anticoagulant service. Journal of Clinical Pathology 1997;50:823-8. [DOI: 10.1136/jcp.50.10.823]2908762
101. Trivalle C, Cartier T, Verny C, Mathieu AM, Davrinche P, Agostini H, et al. Identifying and preventing adverse drug events in elderly hospitalised patients: a randomised trial of a program to reduce adverse drug effects. The Journal of Nutrition, Health and Ageing 2010;14(1):57-61. 2908764
102. Tuiskula KA, Sullivan KM, Abraham G, Lahoz MR. Revising warfarin patient education materials to meet a national patient safety goal. American Journal Health-System Pharmacy 2011;68:974-6. 2908766
103. Turc-Dessertine C. Evaluation of the therapeutic education of the patients under anti-vitamins K treatment in cardiology service/intensive care unit. Recherche en Soins Infirmiers 2005;1(80):59-75. 5372409
104. Vadher B, Patterson DLH, Leaning M. Comparison of oral anticoagulant control by nurse-practitioner using a decision-aid with that by clinicians. British Journal of Haematology 1996;93(1):31. 2908768
105. Vadher B, Patterson DLH, Leaning M. Evaluation of a decision support system for initiation and control of oral anticoagulation in a randomised trial. BMJ 1997;314:1252-6. 2908770
106. Verret L, Couturier J, Rozon A, Saudrais-Janecek S, St-Onge A, Nguyen A, et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy: The Journal of Human Pharmacology & Drug Therapy 2012;32:871-9. 5372411
107. Waterman AD, Miligan PE, Banet GA, Gatchel SK, Gage BF. Establishing and running an effective telephone-based anticoagulation service. Journal of Vascular Nursing 2001;19:4. 2908772
108. Waterman AD, Banet G, Miligan PE, Frazier A, Verzino E, Walton B, et al. Patient and physician satisfaction with a telephone-based anticoagulation service. Journal of General Internal Medicine 2001;16:460-3. 2908774
109. Watzke HH, Forberg E, Svolba G. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thrombosis and Haemostasis 2000;83:661-5. 2908776
110. Winans ARM, Rudd KM, Triller D. Assessing anticoagulation knowledge in patients new to warfarin therapy. The Annals of Pharmacotherapy 2010;44:1152-7. 2908778
111. Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 2005;127:1515-22. [DOI: 10.1378/chest.127.5.1515]2908780
112. Woodend AK. Patient self management of anticoagulants resulted in fewer major complications than clinic-based management. Evidence-Based Nursing 2005;8(3):87. 2908782
113. Wurster M, Doran T. Anticoagulation management: A new approach. Disease Mangement 2006;9(4):201-9. 2908784
114. Yildirim JG, Temel AB. The effect of nurse home-support programme on self-management of the patients receiving oral anticoagulation (Warfarin) therapy. Anadolu Kardiyoloji Dergisi 2015;15:20. 5372413
115. Siebenhofer A, Ulrich LR, Mergenthal K, Roehl I, Rauk S, Berghold A, et al. Primary care management for optimized antithrombotic treatment [PICANT]: study protocol for a cluster randomized controlled trial. Implementation Science 2012;7:79. 5372415
116. Ulrich LR, Mergenthal K, Petersen JJ, Roehl I, Rauk S, Kemperdick B, et al. Anticoagulant treatment in germany family practices- screening results from a cluster randomized controlled trial. BMC Family Practice 2014;15:170. 5372416
117. Ulrich LR, Petersen JJ, Roehl I, Rauck S, Erler A, Kemperdick B, et al. A monitoring list for oral anticoagulation case management in primary care [Eine monitoring-liste fur ein hausarztliches case management bei oraler antikoagulation]. Continuing Medical Education 2013;89(4):165-74. 5372417
118. Aikens JE, Nease DE, Nau PD, Klinkman MS, Schwenk TL. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Annals of Family Medicine 2005;3:23-30.
119. Ansell J, Hirsh J, Poller L, Bussey H, Jacobsen A, Hylek E. The pharmacology and management of the vitamin K antagonists. Chest 2004;126:204-33.
120. Badia X, Arribas F, Ormaetxe JM, Peinado R, de los Terreros MS. Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL). Health and Quality of Life Outcomes 2007;5(37):1-16.
121. Brazier JE, Harper R, Jones NMB, O'Cathain A, Thomas KJ, Usherwood T. Validating the SF-36 health survey questionnaire new outcome measure for primary care. British Medical Journal 1992;305:160-4.
122. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 2014;129:837-847.
123. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional non-adherers: application of the necessity-concerns framework. Journal of Psychosomatic Research 2008;64:41-6.
124. Coehlo-Dantas G, Thomson BV, Manson JA, Tracy CS, Upshur REG. Patients' perspectives on taking warfarin: qualitative study in family practice. BMC Family Practice 2004;5:15. [DOI: 10.1186/1471-2296-5-15]
125. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. American Journal of Cardiology 2013;112:1142-1147.
126. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, RE-LY steering commitee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. New England Journal of Medicine 2009;361:1139-1151.
127. Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, et al. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalised ratio control achieved by centres and countries as measured by time in therapeutic range. Circulation 2008;118:2029-37.
128. Dantas GC, Thomson BV, Manson JA, Tracy CS, Upshur RE. Patients' perspectives on taking warfarin: qualitative study in family practice. BMC Family Practice 2004;5:15.
129. Farmer A, Kinmonth AL, Sutton S. Measuring beliefs about taking hypoglycaemic medication. Diabetic Medicine 2006;23:265-70.
130. Fuller R, Dudley N, Blacktop J. Avoidance hierarchies and preferences for anticoagulation-semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin. Age and Ageing 2004;33:608-11.
131. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Circulation 2006;114:257-354.
132. Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D, Heneghan CJ. Self-monitoring and self-management of oral anticoagulation: Review. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD003839.pub3]
133. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patiel I, Hanyok JJ, Mercuri M, Antman EM, Inverstigators EA-T. Edoxaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine 2013;369:2093-2104.
134. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 10 December 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
135. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek E, Hanna M. Apixaban versus warfarin in patients with atrial fibrillation. The New England Journal of Medicine 2011;365:981-92.
136. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have non-valvular atrial fibrillation. Annals of Internal Medicine 2007;146:857-67.
137. Heeringa J, van der Kuip DA, Hofman A, van Herpen G, Stricker BH, Stijnen J, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. European Heart Journal 2006;27:949-53.
138. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration, March 2011.
139. Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M. Systematic overview of warfarin and its drug and food interactions. Archives of Internal Medicine 2005;165:1095-106.
140. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research 1999;47(6):555-67.
141. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013; Dec 2;8(12):e80633. [DOI: 10.1371/journal.pone.0080633]
142. Howitt A, Armstrong D. Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation. BMJ 1999;318:1324-7.
143. Jackson C, Eliasson L, Barber N, Weinmann J. Applying COM-B to medication adherence: a suggested framework for research and interventions. European Health Psychologist 2014;16(1):_.
144. Jessop DC, Rutter DR. Adherence to asthma medications: the role of illness representations. Psychology and Health 2003;18(5):595-612.
145. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. American Journal of Cardiology 1998;82(8A):2-9.
146. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Vardas P. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal 2016;27(August):1-90.
147. Kok G, Gottleib NH, Peters GJY, Mullen PD, Parecl GS, Ruiter RAC, Fernandez ME, Markham C, Bartholomew K. A taxonomy of behaviour change methods: an intervention mapping approach. Health Psychology Review 2016;10(3):297-312.
148. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, Witteman JC, Stricker BH, Heeringa J. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. European Heart Journal 2013;34:2746-2751.
149. Lane DA, Ponsford J, Shelley A, Sirpal A, Lip GYH. Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy. Journal of Thrombosis and Haemostasis 2006;110:354-8.
150. Lane DA, Aguinaga L, Blomstrom-Lundqvist C, Boriani G, Hills MT, Hylek EM, LaHaye SA, Lip GY, Lobban T, Madrola J, McCabe PJ, Pedersen SS, Pisters R, Stewart S, Wood K, Potpara TS, Gorenek B, Conti JB, Keegan R, Power S, Hendriks J, Ritter P, Calkins H, Violi F, Hurwitz J. Cardiac tachyarrhythmias and patients values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Lationamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). Europace 2015;17:1747-1769.
151. Lane DA, Skjøth F, Lip GYH, Larsen TB, Kotecha D. Temporal trends in incidence, prevalence and mortality of atrial fibrillation in primary care. Journal of the American Heart Association 2017;in Press. [DOI: 10.1161/JAHA.116.005155]
152. Lip GYH, Kamath S, Jafri M, Mohammed A, Bareford D, McAlister FA. Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project. Stroke 2002;33:238-44.
153. Lip GY, Edwards SJ. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thrombosis Research 2006;118:321-33.
154. Lip GYH, Agnelli G, Thach AA, Knight E, Rost D, Tangelder MJ. Oral anticoagulation in atrial fibrillation: a Pan-European Patient Survey. European Journal of Internal Medicine 2007;18:202-8.
155. Lip GYH, Andreotti F, Fauchier L, Huber K, Hylek E, Knight E, et al. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. Europace 2011;13:723-46. [DOI: 10.1093/europace/eur126]
156. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for developing atrial fibrillation: The Framingham Heart Study. Circulation 2004;110:1042-6.
157. McHorney CA, Spain CV. Frequency of and reasons for medication non-fulfilment and non-persistence among American adults with chronic disease. Health Expectations 2011;14(3):307-20.
158. McManus DD, Rienstra N, Benjamin AA. An update on the progress of patients with atrial fibrillation. Circulation 2012;126:e143-6.
159. Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective techniques in healthy eating and physical activity interventions: a meta-regression. Health Psychology 2009;28(6):690-701. [DOI: 10.1037/a0016136]
160. Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implementation Science 2011;6(42).
161. Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behaviour change technique taxonomy (v1) of 93 hierarchically clustered techniques: Building an international consensus for the reporting of behavior change interventions. Annals of Behavioral Medicine 2013;46(1):81-95. [DOI: 10.1007/s12160-013-9486-6]
162. Miyasaka Y, Barnes ME, Gersh BJ. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25.
163. Morgan CL, McEwan P, Tukiendorf A, Robinson PA, Clemens A, Plumb JM. Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control. Thrombosis 2009;124:37-41.
164. Nadar S, Begum N, Kaur B, Sandhu S, Lip GYH. Patients understanding of anticoagulation therapy in a multiethnic population. Journal of the Royal Society of Medicine 2003;96:175-9.
165. Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology 2005;44:762-7.
166. National Collaborating Centre for Chronic Conditions. Atrial fibrillation: national clinical guideline for management in primary and secondary care. London: Royal College of Physicians 2006.
167. Behaviour change at population, community and individual levels. NICE Public Health Guidelines 6 2007.
168. Nunes V, Neilson J, O'Flynn N, Calvert N, Kuntze S, Smithson H, et al. Clinical guidelines and evidence for review for medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. National Collaborating Centre for Primary care and Royal College of General Practitioners 2009.
169. O'Connor AM. Validation of a decision conflict scale. Medical Decision Making 1995;15(1):25-30. [DOI: 10.1177/0272989X9501500105]
170. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. The New England Journal of Medicine 2011;365:883-91.
171. Protheroe J, Fahey T, Montgomery AA, Peters TJ. The impact of patients' preferences on treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ 2000;320:1380-4.
172. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
173. Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thrombosis and Haemostasis 1993;69(3):236-9.
174. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Journal of Thrombosis and Haemostasis 2005;3:692-4.
175. Shantsila A, Lip GYH. Towards (cost) effective cardiovascular risk management: using new drugs vs. the better use of available ones. International Journal of Clinical Practice 2009;64(2):138-40. [DOI: 10.1111/j.1742-1241.2009.02233.x]
176. Sheikh A, Patel NJ, Nalluri N, Agnihotri K, Spagnola J, Patel A, et al. Trends in hospitalization for atrial fibrillation: epidemiology, cost and implications for the future. Progree in Cardiovascular Diseases 2015;58(2):105-16.
177. Spielberger CD, Gorsuch RL, Lushene RE. The stait-trait anxiety inventory. Consulting Psychiatrists Press. California: Palo Alto, 1969.
178. Steed L, Newman SP, Hardman SMC. An examination of the self-regulation model in atrial fibrillation. British Journal of Health Psychology 2010;4(4):337-47. [DOI: 10.1348/135910799168687]
179. Tang E, Lai C, Lee K, Wong RSM, Cheng G, Chan TYK. Relationship between patients warfarin knowledge and anticoagulation control. Annals of Pharmacotherapy 2003;37:34-9.
180. Thrall G, Lip GYH, Lane D. Compliance with pharmacological therapy in hypertension: can we do better, and how?. Journal of Human Hypertension 2004;18:595-7.
181. Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Franzosi MG, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: analysis of the RE-LY trial. Lancet 2010;376(9745):975-83.
182. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). Medical Care 1992;30(6):473-83.
183. White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, Albers GW. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulation control: results from SPORTIF III and V. Archives of Internal Medicine 2007;167(3):239-45.
184. Wofford JL, Wells MD, Singh S. Best strategies for patient education about anticoagulation with warfarin: a systematic review. BMC Health Service Research 2008;8:40.
185. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22(8):983-8.
186. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983;67:361-70.
187. Clarkesmith DE, Pattison HM, Lane DA. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD008600.pub2]